Abl kinase deficiency promotes AKT pathway activation and prostate cancer progression and metastasis
M. A. Marchal, D. Moose, A. Varzavand, D. Taylor, J. A. Brown, M. D. Henry, C. S. Stipp
bioRxiv · May 19, 2020 · PreprintCancer Biology
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
2 papers
Recent·Most cited
M. A. Marchal, D. Moose, A. Varzavand, D. Taylor, J. A. Brown, M. D. Henry, C. S. Stipp
bioRxiv · May 19, 2020 · PreprintCancer Biology
C. R. Feddersen, J. L. Schillo, A. Varzavand, H. R. Vaughn, L. S. Wadsworth, A. P. Voigt, E. Y. Zhu, B. M. Jennings, S. A. Mullen, J. Bobera, J. D. Riordan, C. S. Stipp, A. J. Dupuy
This study identifies DBL family members as drivers of vemurafenib resistance in melanoma and shows that Src inhibition can block this resistance.
bioRxiv · Feb 26, 2019Cancer Biology